$MRZM
Marizyme Inc Stock $mrzm

$mrzm Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-Q Financial Statement

#000149315222031687 Filed on November 14, 2022

Income Statement

Concept	2022 Q4	2022 Q3	2021 Q3
Revenue	$95.66K	$76.01K	$37.22K
YoY Change	-54.51%	104.22%	-70.22%
Cost Of Revenue	$27.79K	$15.50K	$18.36K
YoY Change	-65.41%	-15.58%	-28.59%
Gross Profit	$67.87K	$60.51K	$18.86K
YoY Change	-47.76%	220.84%	-81.0%
Gross Profit Margin	70.95%	79.61%	50.67%
Selling, General & Admin	$1.320M	$1.375M	$1.775M
YoY Change	-81.73%	-22.52%	-18.0%
% of Gross Profit	1945.38%	2272.3%	9409.54%
Research & Development	$680.8K	$708.2K	$241.7K
YoY Change	-59.52%	192.96%
% of Gross Profit	1003.15%	1170.42%	1281.8%
Depreciation & Amortization	$210.4K	$210.4K
YoY Change	379.51%
% of Gross Profit	309.95%	347.65%
Operating Expenses	$2.212M	$2.309M	$1.775M
YoY Change	-75.29%	30.11%	-18.01%
Operating Profit	-$2.144M	-$2.233M	-$1.756M
YoY Change	-75.7%	27.18%	-14.98%
Interest Expense	-$1.149M	-$810.6K	-$70.22K
YoY Change	811.67%	1054.37%
% of Operating Profit
Other Income/Expense, Net	$3.740M	$680.4K	$194.0K
YoY Change	-369.65%	250.72%
Pretax Income	-$23.56M	-$1.553M	-$1.632M
YoY Change	114.26%	-4.86%	-20.97%
Income Tax
% Of Pretax Income
Net Earnings	-$23.56M	-$1.553M	-$1.632M
YoY Change	114.26%	-4.86%	-20.97%
Net Earnings / Revenue	-24633.45%	-2042.62%	-4384.74%
Basic Earnings Per Share		-$0.04	-$0.05
Diluted Earnings Per Share	-$0.58	-$38.03K	-$45.42K
COMMON SHARES
Basic Shares Outstanding	40.53M shares	40.83M shares
Diluted Shares Outstanding		40.83M shares

Balance Sheet

Concept	2022 Q4	2022 Q3	2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$510.9K	$1.182M	$16.67K
YoY Change	-87.46%	6992.08%	-99.68%
Cash & Equivalents	$510.9K	$1.182M	$16.67K
Short-Term Investments
Other Short-Term Assets	$1.126M	$839.8K	$35.00K
YoY Change	337.75%	2299.49%	-84.02%
Inventory	$215.6K	$251.2K	$15.39K
Prepaid Expenses	$1.126M	$839.8K
Receivables	$87.80K	$54.23K	$96.29K
Other Receivables	$15.31K	$14.13K	$0.00
Total Short-Term Assets	$1.955M	$2.342M	$163.4K
YoY Change	-55.58%	1333.49%	-97.12%
LONG-TERM ASSETS
Property, Plant & Equipment	$12.55K	$12.61K	$1.164M
YoY Change	-2.12%	-98.92%	14866.97%
Goodwill	$7.191M	$7.191M
YoY Change	0.0%
Intangibles	$27.68M	$52.24M
YoY Change	-47.65%
Long-Term Investments
YoY Change
Other Assets	$369.1K	$369.1K	$371.0K
YoY Change	0.0%	-0.51%
Total Long-Term Assets	$36.73M	$61.38M	$53.34M
YoY Change	-40.37%	15.09%	24.59%
TOTAL ASSETS
Total Short-Term Assets	$1.955M	$2.342M	$163.4K
Total Long-Term Assets	$36.73M	$61.38M	$53.34M
Total Assets	$38.69M	$63.73M	$53.50M
YoY Change	-41.38%	19.11%	10.35%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.365M	$848.4K	$1.397M
YoY Change	-14.45%	-39.27%	199.7%
Accrued Expenses	$423.5K	$420.9K	$260.1K
YoY Change	52.81%	61.82%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$213.6K	$0.00
YoY Change	-100.0%
Long-Term Debt Due	$1.133M	$213.6K
YoY Change
Total Short-Term Liabilities	$2.922M	$1.606M	$2.296M
YoY Change	-6.76%	-30.04%	392.49%
LONG-TERM LIABILITIES
Long-Term Debt	$2.752M	$1.649M	$179.5K
YoY Change	455.53%	818.76%
Other Long-Term Liabilities	$15.59M	$19.52M	$10.79M
YoY Change	6.21%	80.98%
Total Long-Term Liabilities	$18.34M	$21.17M	$10.97M
YoY Change	20.88%	93.06%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.922M	$1.606M	$2.296M
Total Long-Term Liabilities	$18.34M	$21.17M	$10.97M
Total Liabilities	$21.27M	$22.78M	$13.26M
YoY Change	16.15%	71.75%	2745.28%
SHAREHOLDERS EQUITY
Retained Earnings	-$85.99M	-$62.43M
YoY Change	79.81%
Common Stock	$40.53K	$40.83K
YoY Change	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$17.42M	$40.95M	$40.24M
YoY Change
Total Liabilities & Shareholders Equity	$38.69M	$63.73M	$53.50M
YoY Change	-41.38%	19.11%	10.35%

Cashflow Statement

Concept	2022 Q4	2022 Q3	2021 Q3
OPERATING ACTIVITIES
Net Income	-$23.56M	-$1.553M	-$1.632M
YoY Change	114.26%	-4.86%	-20.97%
Depreciation, Depletion And Amortization	$210.4K	$210.4K
YoY Change	379.51%
Cash From Operating Activities	-$1.586M	-$2.210M	-$1.337M
YoY Change	7.6%	65.27%	75.57%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities			$0.00
YoY Change			-100.0%
Cash From Investing Activities			$0.00
YoY Change			-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	914.7K	1.348M	1.352M
YoY Change	-83.46%	-0.32%	-77.78%
NET CHANGE
Cash From Operating Activities	-1.586M	-2.210M	-1.337M
Cash From Investing Activities			0.000
Cash From Financing Activities	914.7K	1.348M	1.352M
Net Change In Cash	-671.4K	-862.7K	14.56K
YoY Change	-116.55%	-6025.27%	-99.72%
FREE CASH FLOW
Cash From Operating Activities	-$1.586M	-$2.210M	-$1.337M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001413754
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
CY2022Q3	us-gaap	Long Term Notes Payable LongTermNotesPayable		usd
	MRZM	Stockbased Compensation Restricted Common Stock StockbasedCompensationRestrictedCommonStock		usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims		usd
	MRZM	Proceeds From Notes Payable Related Parties ProceedsFromNotesPayableRelatedParties		usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	MRZM	Settlement Of Notes Payable With Convertible Notes SettlementOfNotesPayableWithConvertibleNotes		usd
	MRZM	Contingent Liabilities Noncash ContingentLiabilitiesNoncash		usd
CY2020Q4	us-gaap	Goodwill Goodwill		usd
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss		usd
CY2022Q3	MRZM	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicGranted		usd
CY2022Q3	MRZM	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Expired ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicExpired		usd
CY2022Q3	MRZM	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Forfeited ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicForfeited		usd
	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-53223
	dei	Entity Registrant Name EntityRegistrantName	MARIZYME, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	82-5464863
	dei	Entity Address Address Line1 EntityAddressAddressLine1	555 Heritage Drive
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 205
	dei	Entity Address City Or Town EntityAddressCityOrTown	Jupiter
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33458
	dei	City Area Code CityAreaCode	(925)
	dei	Local Phone Number LocalPhoneNumber	400-3123
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	40528191	shares
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1182248	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4072339	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	54225	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	8650	usd
CY2022Q3	us-gaap	Other Receivables OtherReceivables	14134	usd
CY2021Q4	us-gaap	Other Receivables OtherReceivables	41307	usd
CY2022Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	839818	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	257169	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	251187	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	22353	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	2341612	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	4401818	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12613	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12817	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1576445	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1158776	usd
CY2022Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	52235313	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	52866192	usd
CY2022Q3	MRZM	Prepaid Royalties Noncurrent PrepaidRoyaltiesNoncurrent	339091	usd
CY2021Q4	MRZM	Prepaid Royalties Noncurrent PrepaidRoyaltiesNoncurrent	339091	usd
CY2022Q3	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	30000	usd
CY2021Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	30000	usd
CY2022Q3	us-gaap	Goodwill Goodwill	7190656	usd
CY2021Q4	us-gaap	Goodwill Goodwill	7190656	usd
CY2022Q3	us-gaap	Assets Noncurrent AssetsNoncurrent	61384118	usd
CY2021Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	61597532	usd
CY2022Q3	us-gaap	Assets Assets	63725730	usd
CY2021Q4	us-gaap	Assets Assets	65999350	usd
CY2022Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	848345	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1596147	usd
CY2022Q3	us-gaap	Notes Payable Current NotesPayableCurrent	213563	usd
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	127798	usd
CY2022Q3	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	123266	usd
CY2021Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	1132634	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	420913	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	277142	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	1606087	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3133721	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1155532	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	881634	usd
CY2021Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	469252	usd
CY2022Q3	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	1648795	usd
CY2021Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	26065	usd
CY2022Q3	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	4923725	usd
CY2021Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	2485346	usd
CY2022Q3	MRZM	Contingent Liabilities ContingentLiabilities	13444000	usd
CY2021Q4	MRZM	Contingent Liabilities ContingentLiabilities	11313000	usd
CY2022Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	21172052	usd
CY2021Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	15175297	usd
CY2022Q3	us-gaap	Liabilities Liabilities	22778139	usd
CY2021Q4	us-gaap	Liabilities Liabilities	18309018	usd
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000	shares
CY2022Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	40828188	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	40828188	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	40528188	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	40528188	shares
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	40828	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	40528	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	103331833	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	95473367	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-62425070	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-47823563	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	40947591	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	47690332	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	63725730	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	65999350	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	76012	usd
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	37215	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	137821	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	271952	usd
CY2022Q3	MRZM	Direct Costs Of Revenue DirectCostsOfRevenue	15503	usd
CY2021Q3	MRZM	Direct Costs Of Revenue DirectCostsOfRevenue	18356	usd
	MRZM	Direct Costs Of Revenue DirectCostsOfRevenue	26528	usd
	MRZM	Direct Costs Of Revenue DirectCostsOfRevenue	168419	usd
CY2022Q3	MRZM	Professional Fees Related Parties ProfessionalFeesRelatedParties	155000	usd
CY2021Q3	MRZM	Professional Fees Related Parties ProfessionalFeesRelatedParties	90000	usd
	MRZM	Professional Fees Related Parties ProfessionalFeesRelatedParties	422000	usd
	MRZM	Professional Fees Related Parties ProfessionalFeesRelatedParties	270000	usd
CY2022Q3	us-gaap	Professional Fees ProfessionalFees	303574	usd
CY2021Q3	us-gaap	Professional Fees ProfessionalFees	460378	usd
	us-gaap	Professional Fees ProfessionalFees	1721479	usd
	us-gaap	Professional Fees ProfessionalFees	1445004	usd
CY2022Q3	us-gaap	Salaries And Wages SalariesAndWages	330221	usd
CY2021Q3	us-gaap	Salaries And Wages SalariesAndWages	517192	usd
	us-gaap	Salaries And Wages SalariesAndWages	2147967	usd
	us-gaap	Salaries And Wages SalariesAndWages	2084430	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	708220	usd
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	241748	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3297986	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	877936	usd
CY2022Q3	us-gaap	Employee Benefits And Share Based Compensation Noncash EmployeeBenefitsAndShareBasedCompensationNoncash	271517	usd
CY2021Q3	us-gaap	Employee Benefits And Share Based Compensation Noncash EmployeeBenefitsAndShareBasedCompensationNoncash	64074	usd
	us-gaap	Employee Benefits And Share Based Compensation Noncash EmployeeBenefitsAndShareBasedCompensationNoncash	1664191	usd
	us-gaap	Employee Benefits And Share Based Compensation Noncash EmployeeBenefitsAndShareBasedCompensationNoncash	626449	usd
CY2022Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	210361	usd
CY2021Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1425	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	631083	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	5849	usd
CY2022Q3	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	469656	usd
CY2021Q3	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	489820	usd
	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	1478726	usd
	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	944248	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	2309052	usd
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	1792993	usd
	us-gaap	Operating Expenses OperatingExpenses	10967960	usd
	us-gaap	Operating Expenses OperatingExpenses	6152335	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2233040	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1755778	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-10830139	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-5880383	usd
CY2022Q3	MRZM	Interest And Accretion Expenses Other InterestAndAccretionExpensesOther	-810598	usd
CY2021Q3	MRZM	Interest And Accretion Expenses Other InterestAndAccretionExpensesOther	-70221	usd
	MRZM	Interest And Accretion Expenses Other InterestAndAccretionExpensesOther	-1640368	usd
	MRZM	Interest And Accretion Expenses Other InterestAndAccretionExpensesOther	-74410	usd
CY2022Q3	MRZM	Gain Loss On Fair Value Of Contingent Liabilities GainLossOnFairValueOfContingentLiabilities	1491000	usd
CY2021Q3	MRZM	Gain Loss On Fair Value Of Contingent Liabilities GainLossOnFairValueOfContingentLiabilities	194000	usd
	MRZM	Gain Loss On Fair Value Of Contingent Liabilities GainLossOnFairValueOfContingentLiabilities	-2131000	usd
	MRZM	Gain Loss On Fair Value Of Contingent Liabilities GainLossOnFairValueOfContingentLiabilities	472000	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	680402	usd
CY2021Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	123779	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3771368	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	397590	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-1552638	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-1631999	usd
	us-gaap	Net Income Loss NetIncomeLoss	-14601507	usd
	us-gaap	Net Income Loss NetIncomeLoss	-5482793	usd
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.36
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.15
CY2022Q3	us-gaap	Weighted Average Limited Partnership Units Outstanding WeightedAverageLimitedPartnershipUnitsOutstanding	40828188	shares
CY2021Q3	us-gaap	Weighted Average Limited Partnership Units Outstanding WeightedAverageLimitedPartnershipUnitsOutstanding	35928188	shares
	us-gaap	Weighted Average Limited Partnership Units Outstanding WeightedAverageLimitedPartnershipUnitsOutstanding	40762254	shares
	us-gaap	Weighted Average Limited Partnership Units Outstanding WeightedAverageLimitedPartnershipUnitsOutstanding	35928188	shares
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	45287628	usd
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	334385	usd
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-2211866	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	43410147	usd
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	194657	usd
CY2021Q2	MRZM	Adjustment Of Warrants Value In Connection With Finalizing Business Combination AdjustmentOfWarrantsValueInConnectionWithFinalizingBusinessCombination	-732300	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-1638928	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	41233576	usd
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	64074	usd
CY2021Q3	MRZM	Adjustments To Additional Paid In Capital Warrants Issued In Connection With Convertible Notes AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedInConnectionWithConvertibleNotes	571807	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-1631999	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	40237458	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	47690332	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	716432	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	2969916	usd
CY2022Q1	MRZM	Stock Issued During Period Value Exercise Of Warrants StockIssuedDuringPeriodValueExerciseOfWarrants	3000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-6124885	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	45254795	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	676242	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	2341659	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-6923984	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	41348712	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	41348712	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	271517	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	880000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-1552638	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	40947591	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	40947591	usd
	us-gaap	Profit Loss ProfitLoss	-14601507	usd
	us-gaap	Profit Loss ProfitLoss	-5482793	usd
	MRZM	Depreciation Depletion And Amortization1 DepreciationDepletionAndAmortization1	631083	usd
	MRZM	Depreciation Depletion And Amortization1 DepreciationDepletionAndAmortization1	-76013	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1664191	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	593116	usd
	MRZM	Stockbased Compensation Restricted Common Stock StockbasedCompensationRestrictedCommonStock	33333	usd
	MRZM	Interest And Accretion On Convertible Notes And Notes Payable InterestAndAccretionOnConvertibleNotesAndNotesPayable	1637951	usd
	MRZM	Interest And Accretion On Convertible Notes And Notes Payable InterestAndAccretionOnConvertibleNotesAndNotesPayable	74410	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	1850533	usd
	MRZM	Gain Loss On Fair Value Of Contingent Liabilities GainLossOnFairValueOfContingentLiabilities	-2131000	usd
	MRZM	Gain Loss On Fair Value Of Contingent Liabilities GainLossOnFairValueOfContingentLiabilities	472000	usd
	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	18402	usd
	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	55706	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	582649	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-38057	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	228834	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-40950	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-740034	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	721078	usd
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-1009368	usd
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	272530	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-9266036	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4313038	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	6500743	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	1060949	usd
	MRZM	Proceeds From Notes Payable Related Parties ProceedsFromNotesPayableRelatedParties	366000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	127798	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	3000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6375945	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	4072339	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2902762	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1182248	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	16673	usd
	MRZM	Derivative Liabilities And Debt Discount Issued In Connection With Convertible Notes DerivativeLiabilitiesAndDebtDiscountIssuedInConnectionWithConvertibleNotes	2438379	usd
CY2022Q3	us-gaap	Deferred Offering Costs DeferredOfferingCosts	271240	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1426949	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2890091	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2886089	usd
	MRZM	Derivative Liabilities And Debt Discount Issued In Connection With Convertible Notes DerivativeLiabilitiesAndDebtDiscountIssuedInConnectionWithConvertibleNotes	391648	usd
	MRZM	Warrants And Debt Discount Issued In Connection With Convertible Notes WarrantsAndDebtDiscountIssuedInConnectionWithConvertibleNotes	4341042	usd
	MRZM	Warrants And Debt Discount Issued In Connection With Convertible Notes WarrantsAndDebtDiscountIssuedInConnectionWithConvertibleNotes	571807	usd
	MRZM	Settlement Of Notes Payable With Convertible Notes SettlementOfNotesPayableWithConvertibleNotes	278678	usd
	MRZM	Contingent Liabilities Noncash ContingentLiabilitiesNoncash	9926000	usd
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Incorporation Date Of Incorporation EntityIncorporationDateOfIncorporation	2007-03-20
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-62425070	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-47823563	usd
CY2022Q3	MRZM	Working Capital WorkingCapital	735525	usd
CY2021Q4	MRZM	Working Capital WorkingCapital	1268097	usd
CY2022Q3	us-gaap	Cash Cash	1182248	usd
CY2021Q4	us-gaap	Cash Cash	4072339	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_848_eus-gaap--UseOfEstimates_zZzjXOcMDG1g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_869_zgrdNHWKhp07">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the condensed consolidated financial statements in accordance with U.S. GAAP requires management to make use of certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reported periods. The Company bases its estimates on historical experience and on various other assumptions that management believes are reasonable under the circumstances, the results of which form the basis for making judgments about carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates. Significant estimates are related to the allocation of the purchase price in a business combination to the underlying assets and liabilities, recoverability of long-term assets including intangible assets and goodwill, amortization expense, valuation of warrants, stock-based compensation, derivative liabilities, contingent liabilities and deferred tax valuations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	MRZM	Midrange Average Estimated Interest Rate MidrangeAverageEstimatedInterestRate	0.206	pure
CY2022Q3	us-gaap	Liabilities Fair Value Adjustment LiabilitiesFairValueAdjustment	516000	usd
	us-gaap	Liabilities Fair Value Adjustment LiabilitiesFairValueAdjustment	1288000	usd
	us-gaap	Royalty Expense RoyaltyExpense	5276000	usd
CY2021	us-gaap	Royalty Expense RoyaltyExpense	3988000	usd
CY2022Q3	MRZM	Liquidation Preference Fair Market Value LiquidationPreferenceFairMarketValue	1823000	usd
CY2021Q4	MRZM	Liquidation Preference Fair Market Value LiquidationPreferenceFairMarketValue	1823000	usd
CY2021	us-gaap	Indefinite Lived Intangible Assets Purchase Accounting Adjustments IndefiniteLivedIntangibleAssetsPurchaseAccountingAdjustments	4022271	usd
CY2022Q3	us-gaap	Notes Payable NotesPayable	213563	usd
CY2021Q4	us-gaap	Notes Payable NotesPayable	469252	usd
CY2020Q4	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P5Y6M
CY2020Q4	us-gaap	Area Of Land AreaOfLand	10300
CY2022Q2	us-gaap	Area Of Land AreaOfLand	3053
CY2022Q3	us-gaap	Lessee Operating Lease Remaining Lease Term LesseeOperatingLeaseRemainingLeaseTerm	P3Y9M29D
CY2022Q3	us-gaap	Payments For Rent PaymentsForRent	103291	usd
	us-gaap	Payments For Rent PaymentsForRent	324544	usd
CY2021Q3	us-gaap	Payments For Rent PaymentsForRent	77357	usd
	us-gaap	Payments For Rent PaymentsForRent	168769	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1576445	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1158776	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	420913	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	277142	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1155532	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	881634	usd
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	1576445	usd
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1158776	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	103291	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	423495	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	434082	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	444934	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	266034	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1671836	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	95391	usd
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	1576445	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	53492745	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-1257432	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	52235313	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	53492745	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-626553	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	52866192	usd
CY2021	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	7190656	usd
CY2021Q4	us-gaap	Goodwill Goodwill	7190656	usd
CY2020Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	42278211	usd
CY2021	MRZM	Indefinite Lived Intangible Assets Purchase Accounting Adjustments One IndefiniteLivedIntangibleAssetsPurchaseAccountingAdjustmentsOne	6600000	usd
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
	us-gaap	Stockholders Equity Note Changes In Capital Structure Subsequent Changes To Number Of Common Shares StockholdersEquityNoteChangesInCapitalStructureSubsequentChangesToNumberOfCommonShares	10207212	shares
CY2021	us-gaap	Indefinitelived Intangible Assets Acquired IndefinitelivedIntangibleAssetsAcquired	2775	usd
CY2021	MRZM	Accumulated Amortization Of Intangible Assets AccumulatedAmortizationOfIntangibleAssets	37065	usd
CY2021Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	52866192	usd
	MRZM	Accumulated Amortization Of Intangible Assets AccumulatedAmortizationOfIntangibleAssets	630879	usd
CY2022Q3	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	52235313	usd
CY2022Q3	MRZM	Interest And Accretion Expenses InterestAndAccretionExpenses	805849	usd
	MRZM	Interest And Accretion Expenses InterestAndAccretionExpenses	1622730	usd
CY2021Q3	MRZM	Interest And Accretion Expenses InterestAndAccretionExpenses	70221	usd
	MRZM	Interest And Accretion Expenses InterestAndAccretionExpenses	74410	usd
CY2021Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	26065	usd
	MRZM	Convertible Notes Issued New Securities ConvertibleNotesIssuedNewSecurities	7315138	usd
	MRZM	Deferred Finance Costs DeferredFinanceCosts	535717	usd
	MRZM	Debt Instrument Unamortized Discounts DebtInstrumentUnamortizedDiscounts	6779421	usd
	MRZM	Debt Accretion Expenses DebtAccretionExpenses	1622730	usd
CY2022Q3	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	1648795	usd
CY2022Q3	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	14771177	usd
CY2021Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	7482104	usd
CY2022Q3	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	-13122382	usd
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	-7456039	usd
CY2022Q3	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	1648795	usd
CY2021Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	26065	usd
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000	shares
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	300000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	400000	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1532500	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	40828188	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	40828188	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	40528188	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	40528188	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3800943	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.36
CY2021	MRZM	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term3 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm3	P8Y9M25D
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1532500	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.51
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	1682500	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.36
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3650943	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.24
	MRZM	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term3 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm3	P8Y4M2D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1951117	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	400000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.20
	MRZM	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term Granted SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted	P9Y8M8D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	62502	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue	1.25
	MRZM	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term Expired SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermExpired	P8Y29D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	62498	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.25
	MRZM	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term Forfeited SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermForfeited	P8Y29D
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3925943	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.33
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y9M14D
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	2344489	usd
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	3050664	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1.17
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P7Y4M6D
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	2256558	usd
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	5000000	usd
	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	295750	usd
CY2022Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	20969751	shares
CY2021Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	12144838	shares
CY2022Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	271517	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1664191	usd
CY2021Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	64074	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	626449	usd
CY2022Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	1323100	usd
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y8M15D
	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	133797	usd
	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	149178	usd
CY2022Q3	us-gaap	Prepaid Royalties PrepaidRoyalties	339091	usd
CY2021Q4	us-gaap	Prepaid Royalties PrepaidRoyalties	339091	usd
	MRZM	Royalties Percentage RoyaltiesPercentage	0.10	pure

Files In Submission

Name	View Source	Status
0001493152-22-031687-index-headers.html	Edgar Link	pending
0001493152-22-031687-index.html	Edgar Link	pending
0001493152-22-031687.txt	Edgar Link	pending
0001493152-22-031687-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
form10-q_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
mrzm-20220930.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
mrzm-20220930_cal.xml	Edgar Link	unprocessable
mrzm-20220930_lab.xml	Edgar Link	unprocessable
mrzm-20220930_def.xml	Edgar Link	unprocessable
mrzm-20220930_pre.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MRZM
Marizyme Inc Stock $mrzm

2022 Q4 Form 10-Q Financial Statement

#000149315222031687 Filed on November 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MRZM Marizyme Inc Stock $mrzm

2022 Q4 Form 10-Q Financial Statement

#000149315222031687 Filed on November 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MRZM
Marizyme Inc Stock $mrzm